Efficacy and safety of guanfacine extended-release in the treatment of attention-deficit/hyperactivity disorder in adults: Results of a randomized, double-blind, placebo-controlled study.
Efficacy and safety of guanfacine extended-release in the treatment of attention-deficit/hyperactivity disorder in adults: Results of a randomized, double-blind, placebo-controlled study [link]Paper  bibtex   
@misc{noauthor_efficacy_nodate,
	title = {Efficacy and safety of guanfacine extended-release in the treatment of attention-deficit/hyperactivity disorder in adults: {Results} of a randomized, double-blind, placebo-controlled study},
	url = {https://www.mdlinx.com/journal-summaries/attention-deficit-hyperactivity-disorder-adhd-psychiatric/2020/04/15/7655567?spec=family-medicine},
	urldate = {2020-04-23},
}

Downloads: 0